Brequinar

DRUG2 trials

Sponsors

Clear Creek Bio, Inc.

Conditions

COVID-19COVID-19 Infection

Phase 1

Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19

CompletedNCT04425252

Clear Creek Bio, Inc.COVID-19

Start: 2020-08-19End: 2021-01-12Updated: 2022-02-17

Phase 2

CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19

CompletedNCT04575038

Clear Creek Bio, Inc.COVID-19 Infection

Start: 2020-11-19End: 2021-04-28Updated: 2022-04-19